AstraZeneca plans independent drug supply chains for US and China
|
As geopolitical tensions threaten to disrupt
pharmaceutical supply chains, AstraZeneca is making plans to manufacture
drugs for the U.S. and China ... |
How the rise of fintech in Southeast Asia is powering financial inclusion
Dr Ming Gu still remembers the difficulties when FinVolution, a leading Chinese fintech service provider, set up operations in Indonesia in 2018 ... View article...